Julian Elliot awarded for innovative research
Every day, around 4000 medical research papers are published across the world. Associate Professor Julian Elliot has devised a unique strategy to help combat the 'data deluge'.
Visitor information – Everything you need to know about visiting our sites.
Every day, around 4000 medical research papers are published across the world. Associate Professor Julian Elliot has devised a unique strategy to help combat the 'data deluge'.
Human clinical trials of a world-first peanut allergy treatment will begin in Melbourne next month, with researchers focussing on the molecular parts of the potent nut allergen that are needed to build tolerance, while removing the risk of a severe reaction.
The Alfred's Director of Anaesthesia and Perioperative Medicine, Professor Paul Myles, and his team were today awarded Australian Trial of the Year for their worldwide study exploring the risks associated with aspirin and tranexamic acid (TXA).
The Alfred's PrEPX Study will be available to an additional 600 people, thanks to a $100,000 funding boost from the Victorian AIDS Council (VAC).
A supermarket brand of mouthwash has been shown to help kill off gonorrhoea in the mouth, researchers have found.
The Alfred's ground-breaking study providing people at risk of HIV with access to the life changing medication Pre-exposure prophylaxis (PrEP) expanded into major regional centres for the first time.
Researchers at The Alfred have debunked the commonly-held belief that alcohol in moderation is good for the heart, finding that as little as one drink per day can put people at risk of an irregular heartbeat.
Trauma specialists at The Alfred are urging people to avoid excessive drinking and get home safely this party season after new figures revealed one in four pedestrians seriously injured by cars were intoxicated.
The Alfred and Monash University are set to establish Australia’s first dedicated blood cancer research centre, thanks to a $1.2 million grant from the Australian Cancer Research Foundation (ACRF).
New research from The Alfred could nearly halve the number of people who suffer complications with bleeding following open heart and other major surgery.